Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Purchase |
2024-02-06 10:27 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
66,666 | $0.3 | $20,000 | 359,916 (Direct) |
View |
| 2023-08-22 Purchase |
2023-08-23 08:00 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
27,000 | $1.2658 | $34,177 | 36,772 (Direct) |
View |
| 2023-04-17 Purchase |
2023-04-18 08:00 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
3,100 | $3.2 | $9,920 | 9,251 (Direct) |
View |
| 2021-12-06 Purchase |
2021-12-07 08:30 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
5,000 | $0.9403 | $4,702 | 151,500 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-22 08:47 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
4,500 | $1.1537 | $5,192 | 146,500 (Direct) |
View |
| 2020-08-24 Purchase |
2020-08-25 7:11 pm |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
142,000 | $2.04 | $289,680 | 142,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-08 Option Award |
2024-04-10 9:51 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
80,000 | $0 | 443 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:27 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
133,332 | $0 | 359,916 (Direct) |
View |
| 2023-04-28 Exercise |
2023-05-01 6:59 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
521 | $0 | 38,020 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 7:28 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
6,067 | $0 | 28,768 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-10 5:34 pm |
N/A N/A |
EBET Inc. | EBET | Downs Christopher Director |
6,300 | $0 | 81,300 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 5:12 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
250,000 | $0 | 681,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 09:40 am |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
33,000 | $0.31 | 184,500 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 4:36 pm |
N/A N/A |
Esports Technologies Inc. | EBET | Downs Christopher Director |
6,300 | $0 | 81,300 (Direct) |
View |
Ownership |
2021-04-14 9:52 pm |
N/A 2031-03-05 |
Esports Technologies Inc. | EBET | Downs Christopher Director |
0 | $0 | 75,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:00 pm |
N/A 2031-02-05 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
131,000 | $0 | 431,000 (Direct) |
View |